FDA Hits Guardian Drug for Lack of Quality Controls, Secure Data Post author:Sam Post published:April 11, 2017 Post category:Drug Industry Daily The FDA cited Guardian Drug Company over quality and data storage issues. Source: Drug Industry Daily You Might Also Like White House Outlines New Drug Manufacturing Goals to Improve Supply Chain March 28, 2023 Maker of Generic Abortion Pill Sues FDA to Prevent Potential Enforcement Actions April 20, 2023 Three States Move Forward on Drug Pricing Legislation May 29, 2017
